Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Jeremy M. Shefner, Bill Jacobsen, Stuart Kupfer, Fady I. Malik, Lisa Meng, Jenny Wei, Andrew A Wolff & Stacy A. Rudnicki. (2023) Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-8.
Read now
Read now
Eitan Raveh, Assaf Ben-Shimon, Vova Anisimov, Rivka Kreitman, Edmund Ben-Ami, Elisheva Nechushtan, Nurit Birman & Vivian E Drory. (2023) Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 495-501.
Read now
Read now
Bridget J. Perry, J. Nelson, J.B. Wong & D.M. Kent. (2022) Predicting dysphagia onset in patients with ALS: the ALS dysphagia risk score. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:3-4, pages 271-278.
Read now
Read now
Cory J. Holdom, Shyuan T. Ngo, Pamela A. McCombe, Robert D. Henderson & Frederik J. Steyn. (2022) Low plasma hyaluronan is associated with faster functional decline in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 42-48.
Read now
Read now
Susana Pinto & Mamede De carvalho. (2021) Phrenic nerve study as outcome in clinical trials for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:sup1, pages 9-13.
Read now
Read now
Jesus S. Mora, Angela Genge, Adriano Chio, Conrado J. Estol, Delia Chaverri, Maria Hernández, Saúl Marín, Javier Mascias, Gabriel E. Rodriguez, Monica Povedano, Andrés Paipa, Raul Dominguez, Josep Gamez, Maria Salvado, Christian Lunetta, Carlos Ballario, Nilo Riva, Jessica Mandrioli, Alain Moussy, Jean-Pierre Kinet, Christian Auclair, Patrice Dubreuil, Vincent Arnold, Colin D. Mansfield & Olivier Hermine. (2020) Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 5-14.
Read now
Read now
Carlayne Jackson, Terry Heiman-Patterson, Pamela Kittrell, Tatyana Baranovsky, Glenn McAnanama, Laura Bower, Wendy Agnese & Mike Martin. (2019) Radicava (edaravone) for amyotrophic lateral sclerosis: US experience at 1 year after launch. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 605-610.
Read now
Read now
Angela Genge & Benjamin Brooks. (2019) Edaravone administration in pivotal clinical Study 19. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 298-299.
Read now
Read now
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2019) Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 53-60.
Read now
Read now
John Turnbull. (2018) Is edaravone harmful? (A placebo is not a control). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 477-482.
Read now
Read now
Iyas Daghlas, Teresa E. Lever & Emily Leary. (2018) A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 206-211.
Read now
Read now
Bello Hamidou, Benoit Marin, Geraldine Lautrette, Marie Nicol, William Camu, Philippe Corcia, Marie-Christine Arnes-Bes, Christine Tranchant, Pierre Clavelou, Didier Hannequin, Giroud Maurice, Katell Beauvais, Jean-Christophe Antoine, Véronique Danel-Brunaud, Fausto Viader, Pierre-Marie Preux & Philippe Couratier. (2017) Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment*. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 519-527.
Read now
Read now
Evan de Bie, Bjorn Oskarsson, Nanette C. Joyce, Alina Nicorici, Gregorij Kurillo & Jay J. Han. (2017) Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:1-2, pages 17-23.
Read now
Read now
Articles from other publishers (44)
Shotaro Haji, Koji Fujita, Ryosuke Oki, Yusuke Osaki, Ryosuke Miyamoto, Hiroyuki Morino, Seiichi Nagano, Naoki Atsuta, Yuki Kanazawa, Yuki Matsumoto, Atsuko Arisawa, Hisashi Kawai, Yasutaka Sato, Satoshi Sakaguchi, Kenta Yagi, Tatsuto Hamatani, Tatsuo Kagimura, Hiroaki Yanagawa, Hideki Mochizuki, Manabu Doyu, Gen Sobue, Masafumi Harada & Yuishin Izumi. (2023) An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study. JMIR Research Protocols 12, pages e42032.
Crossref
Crossref
Mengxia Gao, Lingqun Zhu, Jingling Chang, Tianyu Cao, Lianying Song, Chunli Wen, Yi Chen, Yudi Zhuo & Fei Chen. (2022) Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis. Clinical Drug Investigation 43:1, pages 1-11.
Crossref
Crossref
Susan L. Hartmaier, Thomas Rhodes, Suzanne F. Cook, Courtney Schlusser, Chao Chen, Steve Han, Neta Zach, Venkatesha Murthy & Shreya Davé. (2022) Qualitative measures that assess functional disability and quality of life in ALS. Health and Quality of Life Outcomes 20:1.
Crossref
Crossref
Yuko Kobayakawa, Koji Todaka, Yu Hashimoto, Senri Ko, Wataru Shiraishi, Junji Kishimoto, Jun-ichi Kira, Ryo Yamasaki & Noriko Isobe. (2022) A novel quantitative indicator for disease progression rate in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 442, pages 120389.
Crossref
Crossref
Fumihiro Takahashi, Osamu Kano, Yoshito Nagano, Takatomo Yoneoka, Sally Nelson & Yoshiteru Ushirogawa. (2022)
Associations between urate levels and amyotrophic lateral sclerosis functional score with edaravone treatment: Post hoc analysis of studies
MCI186
‐16,
MCI186
‐17, and
MCI186
‐19
. Muscle & Nerve 66:5, pages 583-592.
Crossref
Crossref
Divya Ramamoorthy, Kristen Severson, Soumya Ghosh, Karen Sachs, Emily G. Baxi, Alyssa N. Coyne, Elizabeth Mosmiller, Lindsey Hayes, Aianna Cerezo, Omar Ahmad, Promit Roy, Steven Zeiler, John W. Krakauer, Jonathan Li, Aneesh Donde, Nhan Huynh, Miriam Adam, Brook T. Wassie, Alex Lenail, Natasha Leanna Patel-Murray, Yogindra Raghav, Karen Sachs, Velina Kozareva, Stanislav Tsitkov, Tobias Ehrenberger, Julia A. Kaye, Leandro Lima, Stacia Wyman, Edward Vertudes, Naufa Amirani, Krishna Raja, Reuben Thomas, Ryan G. Lim, Ricardo Miramontes, Jie Wu, Vineet Vaibhav, Andrea Matlock, Vidya Venkatraman, Ronald Holewenski, Niveda Sundararaman, Rakhi Pandey, Danica-Mae Manalo, Aaron Frank, Loren Ornelas, Lindsey Panther, Emilda Gomez, Erick Galvez, Daniel Perez, Imara Meepe, Susan Lei, Louis Pinedo, Chunyan Liu, Ruby Moran, Dhruv Sareen, Barry Landin, Carla Agurto, Guillermo Cecchi, Raquel Norel, Sara Thrower, Sarah Luppino, Alanna Farrar, Lindsay Pothier, Hong Yu, Ervin Sinani, Prasha Vigneswaran, Alexander V. Sherman, S. Michelle Farr, Berhan Mandefro, Hannah Trost, Maria G. Banuelos, Veronica Garcia, Michael Workman, Richie Ho, Robert Baloh, Jennifer Roggenbuck, Matthew B. Harms, Carolyn Prina, Sarah Heintzman, Stephen Kolb, Jennifer Stocksdale, Keona Wang, Todd Morgan, Daragh Heitzman, Arish Jamil, Jennifer Jockel-Balsarotti, Elizabeth Karanja, Jesse Markway, Molly McCallum, Tim Miller, Ben Joslin, Deniz Alibazoglu, Senda Ajroud-Driss, Jay C. Beavers, Mary Bellard, Elizabeth Bruce, Nicholas Maragakis, Merit E. Cudkowicz, James Berry, Terri Thompson, Steven Finkbeiner, Leslie M. Thompson, Jennifer E. Van Eyk, Clive N. Svendsen, Jeffrey D. Rothstein, Jonathan D. Glass, Christina N. Fournier, Alexander Sherman, Christian Lunetta, David Walk, Ghazala Hayat, James Wymer, Kelly Gwathmey, Nicholas Olney, Senda Ajroud-Driss, Terry Heiman-Patterson, Ximena Arcila-Londono, Kenneth Faulconer, Ervin Sanani, Alex Berger, Julia Mirochnick, Todd M. Herrington, James D. Berry, Kenney Ng & Ernest Fraenkel. (2022) Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data. Nature Computational Science 2:9, pages 605-616.
Crossref
Crossref
Gaurav Nepal, Sanjeev Kharel, Megan Ariel Coghlan, Jayant Kumar Yadav, Pawan Parajuli, Kamal Pandit, Yow Ka Shing & Rajeev Ojha. (2022) Amyotrophic lateral sclerosis and retinal changes in optical coherence tomography: A systematic review and meta‐analysis. Brain and Behavior 12:9.
Crossref
Crossref
Bradley Roberts, Frances Theunissen, Francis L. Mastaglia, P. Anthony Akkari & Loren L. Flynn. (2022) Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?. International Journal of Molecular Sciences 23:16, pages 9364.
Crossref
Crossref
Leigh E. Colvin, Zachariah W. Foster, Thor D. Stein, Manisha Thakore‐James, Mohammad Kian Salajegheh, Kendall Carr, Keith R. Spencer, Nazifa Abdul Rauf, Latease Adams, James G. Averill, Sean E. Walker, Ian Robey, Victor E. Alvarez, Bertrand R. Huber, Ann C. McKee, Neil W. Kowall & Christopher B. Brady. (2022)
Utility of the
ALSFRS‐R
for predicting
ALS
and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank
. Muscle & Nerve 66:2, pages 167-174.
Crossref
Crossref
Filipe Gonçalves & Bruno Magalhães. (2021) Effects of prolonged interruption of rehabilitation routines in amyotrophic lateral sclerosis patients. Palliative and Supportive Care 20:3, pages 369-374.
Crossref
Crossref
Paolo Tornese, Stefania Lalli, Antoniangela Cocco & Alberto Albanese. (2022) Review of disease-modifying drug trials in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 93:5, pages 521-529.
Crossref
Crossref
Ozlem Yildiz, Johannes Schroth, Vittoria Lombardi, Valentina Pucino, Yoana Bobeva, Ping Yip, Klaus Schmierer, Claudio Mauro, Timothy Tree, Sian Henson & Andrea Malaspina. (2022) The Expression of Active CD11b Monocytes in Blood and Disease Progression in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:6, pages 3370.
Crossref
Crossref
Alexander G. Thompson, Elizabeth Gray, Nick Verber, Yoana Bobeva, Vittoria Lombardi, Stephanie R. Shepheard, Ozlem Yildiz, Emily Feneberg, Lucy Farrimond, Thanuja Dharmadasa, Pamela Gray, Evan C. Edmond, Jakub Scaber, Delia Gagliardi, Janine Kirby, Thomas M. Jenkins, Pietro Fratta, Christopher J. McDermott, Sanjay G. Manohar, Kevin Talbot, Andrea Malaspina, Pamela J. Shaw & Martin R. Turner. (2022) Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain. Brain Communications 4:1.
Crossref
Crossref
Jonathan S. Katz, Jeffrey D. Rothstein, Merit E. Cudkowicz, Angela Genge, Björn Oskarsson, Avis B. Hains, Chen Chen, Joshua Galanter, Braydon L. Burgess, William Cho, Geoffrey A. Kerchner, Felix L. Yeh, Arundhati Sengupta Ghosh, Sravanthi Cheeti, Logan Brooks, Lee Honigberg, Jessica A. Couch, Michael E. Rothenberg, Flavia Brunstein, Khema R. Sharma, Leonard Berg, James D. Berry & Jonathan D. Glass. (2022)
A Phase 1 study of
GDC
‐0134, a dual leucine zipper kinase inhibitor, in
ALS
. Annals of Clinical and Translational Neurology 9:1, pages 50-66.
Crossref
Crossref
Özden O. Dalgıç, Haoran Wu, F. Safa Erenay, Mustafa Y. Sir, Osman Y. Özaltın, Brian A. Crum & Kalyan S. Pasupathy. (2021) Mapping of critical events in disease progression through binary classification: Application to amyotrophic lateral sclerosis. Journal of Biomedical Informatics 123, pages 103895.
Crossref
Crossref
Ruojie He, Minying Zheng, Ling Lian & Xiaoli Yao. (2021) Milano–Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis. Cells 10:5, pages 1220.
Crossref
Crossref
Kristiana Salmon & Angela Genge. 2021. Spectrums of Amyotrophic Lateral Sclerosis. Spectrums of Amyotrophic Lateral Sclerosis
161
180
.
Elizabeth M. Bald, Christopher S. Nance & Jordan L. Schultz. (2021) Melatonin may slow disease progression in amyotrophic lateral sclerosis: Findings from the Pooled Resource Open‐Access ALS Clinic Trials database. Muscle & Nerve 63:4, pages 572-576.
Crossref
Crossref
Suma Babu, Baileigh G. Hightower, James Chan, Nicole R. Zürcher, Pia Kivisäkk, Chieh-En J. Tseng, Danica L. Sanders, Ashley Robichaud, Haruhiko Banno, Armineuza Evora, Akshata Ashokkumar, Lindsay Pothier, Sabrina Paganoni, Sheena Chew, Joanna Dojillo, Kazuko Matsuda, Mark Gudesblatt, James D. Berry, Merit E. Cudkowicz, Jacob M Hooker & Nazem Atassi. (2021) Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial. NeuroImage: Clinical 30, pages 102672.
Crossref
Crossref
Kazuo Sugimoto, Yi Han, Yuebo Song & Ying Gao. (2020) Correlational Analysis of ALS Progression and Serum NfL Measured by Simoa Assay in Chinese Patients. Frontiers in Neurology 11.
Crossref
Crossref
John Turnbull. (2020) Reappraisal of an ALS trial: unaccounted procedural risk. The Lancet Neurology 19:9, pages 717-718.
Crossref
Crossref
Bruno Miranda, Marta Gromicho, Mariana Pereira, Susana Pinto, Michael Swash & Mamede de Carvalho. (2020) Diaphragmatic CMAP amplitude from phrenic nerve stimulation predicts functional decline in ALS. Journal of Neurology 267:7, pages 2123-2129.
Crossref
Crossref
Júlia Costa, Ana Pronto-Laborinho, Susana Pinto, Marta Gromicho, Sara Bonucci, Erin Tranfield, Catarina Correia, Bruno M. Alexandre & Mamede de Carvalho. (2020) Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases. Scientific Reports 10:1.
Crossref
Crossref
Jeremy Shefner, Terry Heiman‐Patterson, Erik P. Pioro, Martina Wiedau‐Pazos, Shawn Liu, Jeffrey Zhang, Wendy Agnese & Stephen Apple. (2019) Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19). Muscle & Nerve 61:2, pages 218-221.
Crossref
Crossref
Thomas M. Jenkins, James J. P. Alix, Jacob Fingret, Taniya Esmail, Nigel Hoggard, Kathleen Baster, Christopher J. McDermott, Iain D. Wilkinson & Pamela J. Shaw. (2019) Longitudinal multi-modal muscle-based biomarker assessment in motor neuron disease. Journal of Neurology 267:1, pages 244-256.
Crossref
Crossref
Jiaoting Jin, Fangfang Hu, Qiuli Zhang, Qiaoyi Chen, Haining Li, Xing Qin, Rui Jia, Li Kang, Yonghui Dang & Jingxia Dang. (2019) Dominant Heterogeneity of Upper and Lower Motor Neuron Degeneration to Motor Manifestation of Involved Region in Amyotrophic Lateral Sclerosis. Scientific Reports 9:1.
Crossref
Crossref
Alice Pirola, Elisa De Mattia, Andrea Lizio, Giulia Sannicolò, Elena Carraro, Fabrizio Rao, Valeria Sansone & Christian Lunetta. (2019) The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients. Clinical Neurology and Neurosurgery 184, pages 105456.
Crossref
Crossref
Julia Costa, Linda Streich, Susana Pinto, Ana Pronto-Laborinho, Manfred Nimtz, Harald S. Conradt & Mamede de Carvalho. (2019) Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis. Molecular Neurobiology 56:8, pages 5729-5739.
Crossref
Crossref
Özden O. Dalgıç, F. Safa Erenay, Kalyan S. Pasupathy, Osman Y. Özaltın, Brian A. Crum & Mustafa Y. Sir. (2019) Tollgate-based progression pathways of ALS patients. Journal of Neurology 266:3, pages 755-765.
Crossref
Crossref
Malcolm Proudfoot, Peter Bede & Martin R. Turner. (2019) Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 9.
Crossref
Crossref
Alex G. Karanevich, Jeffrey M. Statland, Byron J. Gajewski & Jianghua He. (2018) Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression. BMC Medical Research Methodology 18:1.
Crossref
Crossref
Nicholas T. Olney, Antje Bischof, Howard Rosen, Eduardo Caverzasi, William A. Stern, Catherine Lomen-Hoerth, Bruce L. Miller, Roland G. Henry & Nico Papinutto. (2018) Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease. PLOS ONE 13:11, pages e0208255.
Crossref
Crossref
Sofia Pires, Marta Gromicho, Susana Pinto, Mamede Carvalho & Sara C. Madeira. (2018) Predicting Non-invasive Ventilation in ALS Patients Using Stratified Disease Progression Groups. Predicting Non-invasive Ventilation in ALS Patients Using Stratified Disease Progression Groups.
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2018) Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. Frontiers in Neurology 9.
Crossref
Crossref
Nimish J. Thakore, Brittany R. Lapin & Erik P. Pioro. (2018) Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort. Muscle & Nerve 57:6, pages 937-945.
Crossref
Crossref
Thomas M Jenkins, James J P Alix, Charlotte David, Eilish Pearson, D Ganesh Rao, Nigel Hoggard, Eoghan O’Brien, Kathleen Baster, Michael Bradburn, Julia Bigley, Christopher J McDermott, Iain D Wilkinson & Pamela J Shaw. (2018) Imaging muscle as a potential biomarker of denervation in motor neuron disease. Journal of Neurology, Neurosurgery & Psychiatry 89:3, pages 248-255.
Crossref
Crossref
Emily FenebergPatrick OecklPetra SteinackerFederico VerdeChristian BarroPhilip Van DammeElizabeth GrayJulian GrosskreutzClaude JardelJens KuhleSonja KoernerFoudil LamariMaria del Mar AmadorBenjamin MayerClaudia MorelliPetra MuckovaSusanne PetriKoen PoesenJoost RaaphorstFrançois SalachasVincenzo SilaniBeatrice StubendorffMartin R. TurnerMarcel M. VerbeekJochen H. WeishauptPatrick WeydtAlbert C. LudolphMarkus Otto. (2018) Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis. Neurology 90:1.
Crossref
Crossref
Mary K. FloeterBryan J. TraynorJennifer FarrenLaura E. BraunMichael TierneyEdythe A. WiggsTianxia Wu. (2017)
Disease progression in
C9orf72
mutation carriers
. Neurology 89:3, pages 234-241.
Crossref
Crossref
James Rooney, Tom Burke, Alice Vajda, Mark Heverin & Orla Hardiman. (2017) What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 88:5, pages 381-385.
Crossref
Crossref
Eva Syková, Petr Rychmach, Ivana Drahorádová, ŠImona Konrádová, Kateřina Růžičková, Ivan Voříšek, Serhiy Forostyak, Aleš Homola & Martin Bojar. (2017) Transplantation of Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial. Cell Transplantation 26:4, pages 647-658.
Crossref
Crossref
Ricarda A. L. Menke, Federica Agosta, Julian Grosskreutz, Massimo Filippi & Martin R. Turner. (2016) Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis. Neurotherapeutics 14:1, pages 11-23.
Crossref
Crossref
Robert D. Henderson & Pamela A. McCombe. (2016) Assessment of Motor Units in Neuromuscular Disease. Neurotherapeutics 14:1, pages 69-77.
Crossref
Crossref
Albert A. Taylor, Christina Fournier, Meraida Polak, Liuxia Wang, Neta Zach, Mike Keymer, Jonathan D. Glass & David L. Ennist. (2016) Predicting disease progression in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 3:11, pages 866-875.
Crossref
Crossref
Ammar Al-Chalabi, Orla Hardiman, Matthew C Kiernan, Adriano Chiò, Benjamin Rix-Brooks & Leonard H van den Berg. (2016) Amyotrophic lateral sclerosis: moving towards a new classification system. The Lancet Neurology 15:11, pages 1182-1194.
Crossref
Crossref